Compare GTLB & CGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GTLB | CGC |
|---|---|---|
| Founded | 2011 | N/A |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | EDP Services | Pharmaceuticals and Biotechnology |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.5B | 467.3M |
| IPO Year | 2021 | 2023 |
| Metric | GTLB | CGC |
|---|---|---|
| Price | $47.03 | $0.92 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 27 | 1 |
| Target Price | ★ $37.17 | N/A |
| AVG Volume (30 Days) | ★ 5.5M | 3.6M |
| Earning Date | 06-09-2026 | 05-29-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 84.17 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $955,224,000.00 | $12,759,000.00 |
| Revenue This Year | $18.72 | $8.27 |
| Revenue Next Year | $16.05 | $15.68 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 25.81 | N/A |
| 52 Week Low | $18.73 | $0.84 |
| 52 Week High | $55.55 | $2.38 |
| Indicator | GTLB | CGC |
|---|---|---|
| Relative Strength Index (RSI) | 62.42 | 35.72 |
| Support Level | $36.50 | $0.91 |
| Resistance Level | $55.55 | $1.15 |
| Average True Range (ATR) | 2.17 | 0.03 |
| MACD | -0.04 | -0.01 |
| Stochastic Oscillator | 47.18 | 0.70 |
GitLab Inc operates on an all-remote model. GitLab is a complete DevSecOps platform delivered as a single application. It operates in two competitive landscapes: DevOps point solutions and DevOps platforms. In terms of point solutions that are stitched together, GitLab's offering is substantially different in that it is one platform, one codebase, one interface, and a unified data model that spans the entire DevSecOps lifecycle. DevOps platforms, the principal competitor is Microsoft Corporation, following their acquisition of GitHub. GitLab is offered on both self-managed and software-as-a-service (SaaS) models. It is located in the United States, Europe, & the Asia Pacific. It focused on accelerating innovation & broadening the distribution of its platform to companies across the world.
Canopy Growth Corp is a cannabis company that produces, distributes, and sells a diverse range of cannabis and cannabis-related products for adult-use and medical purposes under a portfolio of distinct brands in Canada. The Company supplies cannabis products in Canada, Europe, and Australia. It is focused on the medical and adult-use cannabis markets in Canada, offering a broad portfolio of brands and formats for medical cannabis patients and adult-use consumers. The Company operates through two reportable segments: Cannabis, which generates maximum revenue and includes the production, distribution, and sale of cannabis and cannabis-related products, and Storz & Bickel, which includes the production, distribution, and sale of vaporizers and accessories.